Bruno Sangro
Author
Alternate names Bruno Sangro Gómez‐Acebo, Bruno Sangro, Bernhard Scheiner, B. Sangro
Past institutions Clinica Universidad de Navarra, Navarre Institute of Health Research, Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, University of California, San Diego +5 more
ORCID: Yes
H-index: 88
I10-index: 289
Works count: 788
Citations count: 40,580
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
2017 · Anthony B. El-Khoueiry, Bruno Sangro, et al. · The Lancet
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 · María Reig, Alejandro Forner, et al. · Journal of Hepatology
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 · Philip J. Johnson, Sarah Berhane, et al. · Journal of Clinical Oncology